The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy.

• Sujuan Ba, Ph.D., Co-Chair, CEO & Co-Founder, AIM-HI Accelerator Fund; President & CEO, National Foundation for Cancer Research
• Webster Cavenee, Ph.D., Co-Chair, Distinguished Professor Emeritus, University of California San Diego
• Bahija Jallal, Ph.D., CEO & Director of the Board, Immunocore
• Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School
• Patricia Obermaier, MBA, Chief Growth Officer, Global Health and Life Sciences, Microsoft
• Libia Scheller, Ph.D., MBA, Global Head Oncology-Cooperative Groups & Strategic Alliances, Bayer Health Care Pharmaceuticals
• Thea Tlsty, Ph.D., Professor, Department of Pathology and Director of the Center for Translational Research in the Molecular Genetics of Cancer, UCSF

Please click here to read the press release. We encourage you to join our Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship to celebrate the 2024 Beacon Award winner and hear inspiring speeches and discussions from world-class researchers, clinicians, entrepreneurs, industry leaders, investors, advocates, and cancer patients and survivors.